Period Ending | Dec 31, 2009 | Dec 31, 2008 |
Total Revenue
|
62,080,000
|
63,640,000
| Cost of Revenue | 9,022,000 | 47,263,000 | |
Gross Profit
|
16,013,000
|
16,377,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
|
Selling General and Administrative | 42,915,000 | 6,001,000 |
|
Non Recurring | 29,000 | 84,000 |
|
Others | 74,000 | 44,000 |
|
|
|
Total Operating Expenses |
-
|
-
| | |
Operating Income or Loss
|
10,040,000
|
10,248,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
| 217,000 |
|
Earnings Before Interest And Taxes | 9,243,000 | 10,465,000 |
|
Interest Expense |
-
| 528,000 |
|
Income Before Tax | 9,243,000 | 9,937,000 |
|
Income Tax Expense | 2,691,000 | 2,787,000 |
|
Minority Interest | (210,000) | (260,000) |
|
|
|
Net Income From Continuing Ops | 6,342,000 | 6,890,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
|
Extraordinary Items |
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
|
Other Items |
-
|
-
| | |
Net Income
|
6,342,000
|
6,890,000
| Preferred Stock And Other Adjustments |
-
|
-
| |
Net Income Applicable To Common Shares
|
$6,342,000
|
$6,890,000
|
|